0001544227-20-000031.txt : 20200623
0001544227-20-000031.hdr.sgml : 20200623
20200623070619
ACCESSION NUMBER: 0001544227-20-000031
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200622
FILED AS OF DATE: 20200623
DATE AS OF CHANGE: 20200623
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Dable Habib J
CENTRAL INDEX KEY: 0001690773
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35890
FILM NUMBER: 20980269
MAIL ADDRESS:
STREET 1: C/O ACCELERON PHARMA INC.
STREET 2: 128 SIDNEY STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Millendo Therapeutics, Inc.
CENTRAL INDEX KEY: 0001544227
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 451472564
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 110 MILLER AVENUE, SUITE 100
CITY: ANN ARBOR
STATE: MI
ZIP: 48104
BUSINESS PHONE: 734-845-9000
MAIL ADDRESS:
STREET 1: 110 MILLER AVENUE, SUITE 100
CITY: ANN ARBOR
STATE: MI
ZIP: 48104
FORMER COMPANY:
FORMER CONFORMED NAME: OvaScience, Inc.
DATE OF NAME CHANGE: 20120308
4
1
wf-form4_159291036057257.xml
FORM 4
X0306
4
2020-06-22
0
0001544227
Millendo Therapeutics, Inc.
MLND
0001690773
Dable Habib J
C/O MILLENDO THERAPEUTICS, INC.
110 MILLER AVENUE, SUITE 100
ANN ARBOR
MI
48104
1
0
0
0
Stock Option (right to buy)
2.4
2020-06-22
4
A
0
12000
0
A
2030-06-21
Common Stock
12000.0
12000
D
One hundred percent (100%) of the shares subject to this option will vest on the earlier of (1) June 22, 2021 and (2) the date of the first Annual Meeting following the grant date, subject to the Reporting Person continuing to provide service to the Issuer through such date.
/s/ Jason Minio, Attorney-in-Fact
2020-06-23